WHAT AND WHERE IS HEAVEN?

Does heaven exist? With well over 100,000 plus recorded and described spiritual experiences collected over 15 years, to base the answer on, science can now categorically say yes. Furthermore, you can see the evidence for free on the website allaboutheaven.org.

Available on Amazon
https://www.amazon.com/dp/B086J9VKZD
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)

VISIONS AND HALLUCINATIONS

This book, which covers Visions and hallucinations, explains what causes them and summarises how many hallucinations have been caused by each event or activity. It also provides specific help with questions people have asked us, such as ‘Is my medication giving me hallucinations?’.

Available on Amazon
https://www.amazon.com/dp/B088GP64MW 
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)


Observations placeholder

Nucynta and Nucynta er

Identifier

024113

Type of Spiritual Experience

Hallucination

Number of hallucinations: 201

Background

A description of the experience

Tapentadol (brand names: Nucynta, Palexia and Tapal) is a centrally acting opioid analgesic of the benzenoid class with a dual mode of action as an agonist of the μ-opioid receptor and as a norepinephrine reuptake inhibitor (NRI). Analgesia occurs within 32 minutes of oral administration, and lasts for 4–6 hours.

It is similar to tramadol in its dual mechanism of action; namely, its ability to activate the mu opioid receptor and inhibit the reuptake of norepinephrine. Unlike tramadol, it has only weak effects on the reuptake of serotonin and is a significantly more potent opioid with no known active metabolites. Tapentadol is not a pro-drug and therefore does not rely on metabolism to produce its therapeutic effects; this makes it a useful moderate-potency analgesic option for patients who do not respond adequately to more commonly used opioids due to genetic disposition (poor metabolizers of CYP3A4 and CYP2D6), as well as providing a more consistent dosage-response range among the patient population.

Tapentadol general potency is somewhere between that of tramadol and morphine, with an analgesic efficacy comparable to that of oxycodone despite a lower incidence of side effects. It is generally regarded as a weak-moderate strength opioid.

Most common Nucynta side effects from eHealthme

  • Drug ineffective - (404 reports)
  • Nausea - (249 reports)
  • Pain - (231 reports)
  • Dizziness - (181 reports)
  • Headache - (169 reports)
  • Feeling abnormal - (166 reports)
  • Drowsiness - (156 reports)
  • Fatigue - (151 reports)
  • Confusional state - (148 reports)
  • Depression - (148 reports)

On Jan, 25, 2017  3,693 people reported to have side effects when taking Nucynta.
Among them, 97 people (2.63%) have Death

On Jan, 26, 2017 3,693 people reported to have side effects when taking Nucynta. Among them, 139 people (3.76%) have Hallucination

On Jan, 29, 2017  3,693 people reported to have side effects when taking Nucynta. Among them, 24 people (0.65%) have Hallucination, Auditory

Most common Nucynta er side effects

  • Drug ineffective - (190 reports)
  • Drowsiness - (69 reports)
  • Pain - (66 reports)
  • Nausea - (53 reports)
  • Headache - (53 reports)
  • Serotonin syndrome - (50 reports)
  • Feeling abnormal - (48 reports)
  • Dizziness - (44 reports)
  • High blood pressure - (42 reports)
  • Withdrawal syndrome - (41 reports)

On Feb, 07, 2017  1,179 people reported to have side effects when taking Nucynta Er. Among them, 35 people (2.97%) have Hallucination

On Jan, 18, 2017  1,179 people reported to have side effects when taking Nucynta Er. Among them, 3 people (0.25%) have Hallucination, Auditory

The source of the experience

eHealthme

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Commonsteps

Hearing voices

References